Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
27 Survival analysis | The Epidemiologist R Handbook
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports
Frontiers | Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research
Clinical Trial Endpoints for Oncology Studies
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
Full article: The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors - Matthew Lei, Angela Michael, Seema Patel, Ding Wang, 2019
Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram
Survival in IPF patients. Overall survival was defined as the time from... | Download Scientific Diagram
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) | Respiratory Research | Full Text
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Measures of Cancer Survival
Cancers | Free Full-Text | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
